Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
November 10 2022 - 09:12AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR
15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
November 10, 2022
Commission File Number: 001-39363
IMMATICS N.V.
Paul-Ehrlich-Straße 15
72076 Tübingen, Federal Republic of Germany
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file
annual reports under cover of Form 20-F or Form 40-F:
Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(1):
☐
Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(7):
☐
INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K
On November 10, 2022, Immatics N.V. (the “Company” or “Immatics”)
made available two posters, which are attached as Exhibit 99.1 and
99.2 to this Report on Form 6-K.
EXHIBIT INDEX
| Exhibit No. |
Description |
| 99.1 |
Next-Generation TCR Bispecifics (TCER) Targeting Peptide-HLA
Antigens for the Treatment of Patients with Solid Tumors |
| 99.2 |
The PRAME Opportunity – High Peptide Copy Numbers, Homogenous
Expression and High Prevalence to Address a Broad Patient
Population across Different Solid Cancers with TCR-based
Therapeutics |
| |
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned, thereunto duly authorized.
| |
IMMATICS N.V. |
| |
|
| Date: November 10, 2022 |
|
| |
By: |
/s/ Harpreet
Singh |
| |
Name: |
Harpreet Singh |
| |
Title: |
Chief Executive Officer |
Immatics NV (NASDAQ:IMTX)
Historical Stock Chart
From May 2023 to Jun 2023
Immatics NV (NASDAQ:IMTX)
Historical Stock Chart
From Jun 2022 to Jun 2023
